Napp launches Neulasta biosimilar in UKNapp’s Pelmeg, a biosimilar of Amgen’s cancer drug Neulasta (pegfilgrastim), has been launched in the UK following approval Share XNapp launches Neulasta biosimilar in UKhttps://pharmaphorum.com/news/napp-launches-neulasta-biosimilar-in-uk/
Has the NHS joined the biosimilars revolution?Biosimilars have cut the price of biologic drugs by up to 80% on the NHS, according to Paul Share XHas the NHS joined the biosimilars revolution?https://pharmaphorum.com/oncology/nhs-joined-biosimilar-revolution/
